Stefan Erfurt
| Aktuelle Position: | Doktorand am Institut für Biochemie & Department für Nephrologie |
| Fachbereich: | Biochemie |
| Einrichtung: | Nephrologie, IAG MMKE |
| Adresse: |
Campus Brandenburg an der Havel
Haus 11, 2. OG, Raum 3.15
Hochstraße 29
14770 Brandenburg |
| Telefon: | +49 3381 41-2676 |
| E-Mail: | stefan.erfurt@mhb-fontane.de |
| Forschung: | acute kidney injury (AKI) |
Publikationen
Meine besten 5 Publikationen:
-
Erfurt S, Lauxmann M, Asmus K, Oess S, Patschan D, Hoffmeister M. Serum Nostrin—A risk factor of death, kidney replacement therapy and acute kidney disease in acute kidney injury. PLOS ONE. 11. April 2024;19(4):e0299131. https://doi.org/10.1371/journal.pone.0299131
-
Erfurt S, Hoffmeister M, Oess S, Asmus K, Patschan S, Ritter O, u. a. Soluble IL-33 receptor predicts survival in acute kidney injury. Journal of Circulating Biomarkers. 6. Juni 2022;11:28–35. https://doi.org/10.33393/jcb.2022.2386
-
Patschan D, Erfurt S, Oess S, Lauxmann M, Patschan S, Ritter O, u. a. Biomarker-Based Prediction of Survival and Recovery of Kidney Function in Acute Kidney Injury. KBR. 9. Februar 2023;1–1. https://doi.org/10.1159/000528633
-
Erfurt S, Hoffmeister M, Oess S, Asmus K, Ritter O, Patschan S, u. a. Serum IL-33 as a biomarker in different diseases: useful parameter or much need for clarification? Journal of Circulating Bi-omarkers. 30. November 2021;10(1):20–5. https://doi.org/10.33393/jcb.2021.2327
-
Marahrens B, Amann K, Asmus K, Erfurt S, Patschan D. Renal replacement therapy-requiring acute kidney injury due to tubulointerstitial nephritis and uveitis syndrome: case report. Journal of Medical Case Reports. 20. Dezember 2021;15(1):629. https://doi.org/10.1186/s13256-021-03147-z
